Health Canada has recalled these eye drops — here's why
Health Canada has issued a recall notice on all lots of Cromolyn Eye Drops produced by Pendopharm Division of Pharmascience ...
Verywell Health on MSN12mon
What Is Conjunctivitis?
Medically reviewed by Johnstone M. Kim, MDMedically reviewed by Johnstone M. Kim, MD Conjunctivitis, also known as pink eye, ...
ophthalmologytimes1d
AAO 2024: Livionex reports positive end-of-phase 2 meeting with FDA on the development of C-KAD eye drop to treat early to moderate cataracts
According to the company, there are no FDA-approved pharmacological therapies for age-related cataracts. Its C-KAD eye drop, ...
Becker's Hospital Review21h
New cancer drug tied to vision loss, study suggests
New study reveals potential vision loss in over 55% of ovarian cancer patients taking Elahere, prompting FDA label warning and recommendations for eye care.
Medscape2d
Preservatives in Topical Ophthalmic Medications: Historical and Clinical Perspectives
[19] EDTA has also been used in eye washes to aid in neutralization of calcium hydroxide or lime burns to the cornea. Polyquad ® is a detergent-type preservative derived from BAK. Polyquad was ...
Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024
About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...
Zacks.com on MSN11d
Oculis Holding AG (OCS) Surges 8.2%: Is This an Indication of Further Gains?
Oculis Holding AG (OCS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis
Warren Buffett, renowned as the 'Oracle of Omaha,' once remarked, 'The stock market is a device for transferring money from the ...
Great Pet Care on MSN5mon
Cataract Surgery for Dogs: Cost, Procedure, and What to Expect
At this point, your dog will be on a cocktail of topical eye drops, each of which will need to be applied 4-6 times a day and ...
Morningstar4d
Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024
It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; licaminlimab (OCS-02), a topical ...